Singapore markets closed

UroGen Pharma Ltd. (0XOD.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
14.90-0.55 (-3.55%)
At close: 06:44PM GMT
Full screen
Previous close15.45
Open15.18
Bid0.00 x N/A
Ask0.00 x N/A
Day's range14.90 - 15.18
52-week range7.83 - 24.01
Volume501
Avg. volume457
Market cap2.085M
Beta (5Y monthly)1.10
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

    PRINCETON, N.J., March 14, 2024--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an overview of recent developments.

  • Business Wire

    UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    PRINCETON, N.J., March 08, 2024--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units ("RSUs") to 12 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution, UroGen’s first approved product, and the con

  • Business Wire

    UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024

    PRINCETON, N.J., March 04, 2024--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report fourth quarter and full-year 2023 financial results on Thursday, March 14, 2024, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.